Literature DB >> 19919294

DNA replication, development and cancer: a homeotic connection?

Arturo Falaschi1, Gulnara Abdurashidova, Giuseppe Biamonti.   

Abstract

The homeotic proteins are transcription factors, highly conserved in metazoan organisms, exerting a pivotal role in development and differentiation. They individually display a loose specificity for the DNA sequence they can bind, but operate mainly in multi-molecular associations that assure their target and function specificity. Homeotic proteins are known to play a role in the positive or negative regulation of cell proliferation. Furthermore, many homeotic proteins are actually proto-oncogenes, since different translocations involving their genes cause tumors, particularly in the hematopoietic system. A one-hybrid screen to detect proteins with affinity for the lamin B2 replication origin identified three homeotic proteins, namely HoxA13, HoxC10 and HoxC13. Recent data demonstrate that the HoxC13 oncoprotein specifically associates with replication foci and binds in vitro and in vivo to several human DNA replication origins. Moreover, Hox proteins interact with geminin, a regulator of cell cycle progression, and control the interaction of this protein with the DNA replication licensing factor Ctd1. Thus, the homeotic proteins, by participating directly in the function of DNA replication origins, may provide a direct link between the accurate regulation of DNA replication required by the morphogenetic program and the deregulation of this process typical of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19919294     DOI: 10.3109/10409230903365608

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  9 in total

Review 1.  Role of Hox genes in stem cell differentiation.

Authors:  Anne Seifert; David F Werheid; Silvana M Knapp; Edda Tobiasch
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

2.  Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.

Authors:  Thushangi N Pathiraja; Shweta R Nayak; Yuanxin Xi; Shiming Jiang; Jason P Garee; Dean P Edwards; Adrian V Lee; Jian Chen; Martin J Shea; Richard J Santen; Frank Gannon; Sara Kangaspeska; Jaroslav Jelinek; Jean-Pierre J Issa; Jennifer K Richer; Anthony Elias; Marie McIlroy; Leonie S Young; Nancy E Davidson; Rachel Schiff; Wei Li; Steffi Oesterreich
Journal:  Sci Transl Med       Date:  2014-03-26       Impact factor: 17.956

3.  Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and induces apoptosis in tumor cells and over expression of HOXC13 induces 3D-colony formation.

Authors:  Sahba Kasiri; Khairul I Ansari; Imran Hussain; Arunoday Bhan; Subhrangsu S Mandal
Journal:  RSC Adv       Date:  2012-12-18       Impact factor: 3.361

4.  The N-terminus of the human RecQL4 helicase is a homeodomain-like DNA interaction motif.

Authors:  Oliver Ohlenschläger; Anja Kuhnert; Annerose Schneider; Sebastian Haumann; Peter Bellstedt; Heidi Keller; Hans-Peter Saluz; Peter Hortschansky; Frank Hänel; Frank Grosse; Matthias Görlach; Helmut Pospiech
Journal:  Nucleic Acids Res       Date:  2012-06-22       Impact factor: 16.971

5.  Homeotic proteins participate in the function of human-DNA replication origins.

Authors:  Laura Marchetti; Laura Comelli; Barbara D'Innocenzo; Luca Puzzi; Stefano Luin; Daniele Arosio; Mariantonietta Calvello; Ramiro Mendoza-Maldonado; Fiorenzo Peverali; Fabio Trovato; Silvano Riva; Giuseppe Biamonti; Gulnara Abdurashidova; Fabio Beltram; Arturo Falaschi
Journal:  Nucleic Acids Res       Date:  2010-08-06       Impact factor: 16.971

6.  Spotlight on geminin.

Authors:  Melvin L DePamphilis
Journal:  Breast Cancer Res       Date:  2011-06-01       Impact factor: 6.466

7.  The expression of HOXC10 is correlated with tumor-infiltrating immune cells in basal-like breast cancer and serves as a prognostic biomarker.

Authors:  Xiaobei Zhang; Ying Zheng; Xiaofeng Liu; Kaiyuan Wang; Hongwei Zhao; Yiqing Yin; Yue Yu
Journal:  Ann Transl Med       Date:  2022-01

8.  Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment.

Authors:  Rosaria Chilà; Michela Chiappa; Federica Guffanti; Nicolò Panini; Donatella Conconi; Andrea Rinaldi; Luciano Cascione; Francesco Bertoni; Maddalena Fratelli; Giovanna Damia
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

9.  Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.

Authors:  Xianxiao Zhou; Tongwei Shi; Bailiang Li; Yuannv Zhang; Xiaopei Shen; Hongdong Li; Guini Hong; Chunyang Liu; Zheng Guo
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.